| Metric | Value ($ M) | Q1 FY25 |
|---|---|---|
| Revenue | 8.77 | 9.5% |
| Total Income | 8.77 | 9.5% |
| Expenditure | 10.84 | 47.9% |
| PBT | -2.07 | 404.4% |
| Net Profit | -1.59 | 418.0% |
| OPM | — | |
| NPM | -18.11% | 24.33pp |
| EPS | -0.03 | 400.0% |
Health In Tech Reports Q1 2026 Revenue Up 9.4% to $8.8 Million
14 May 2026 · 14 May, 1:57 am
Summary
Health In Tech announced its Q1 2026 financial results, with revenue increasing by 9.4% to $8.8 million compared to the same period last year. The company reported a net loss of $1.6 million, or $(0.03) per diluted share, a decrease compared to the net income of $0.5 million, or $0.01 per diluted share, in Q1 2025. Adjusted EBITDA totaled $(1.3) million, reflecting higher sales and marketing expenses. The company reiterated its full-year revenue guidance of $45 million to $50 million, representing a year-over-year growth of approximately 35% to 50%.
Key Highlights
- 1
Health In Tech's revenue increased by 9.4% to $8.8 million in the first quarter of 2026, compared to $8.0 million in the first quarter of 2025.
- 2
The platform placed plan value totaled $82.0 million during the quarter.
- 3
The company's adjusted EBITDA totaled $(1.3) million, compared to $1.2 million in the first quarter of 2025.
- 4
Net loss equaled $1.6 million, or $(0.03) per diluted share, compared to net income of $0.5 million, or $0.01 per diluted share, in the first quarter of 2025.
- 5
Distribution partners reached 896, up 29.5% from 692 as of March 31, 2025.
- 6
Contracted revenue for the remaining three quarters of 2026 equaled $22.9 million.
- 7
The company reiterated guidance for 2026 annual revenue ranging between $45 million and $50 million, representing year-over-year growth of approximately 35% to 50%.
Management Comments
Tim Johnson
In the first quarter of 2026, we continued to execute on strategic priorities to scale our innovative AI-powered self-funded health insurance marketplace and drive revenue growth. In March, we successfully completed a private investment in public equity financing, which provided the Company with approximately $7 million in gross proceeds. We intend to allocate a portion of these proceeds to growth initiatives, including expanding our sales team, broadening our marketing activities, delivering new marketplace offerings, and enhancing the technology architecture and data analytics that underpin our disruptive platform. Through these measures we aim to increase the number of brokers, agencies, third party administrators, and carriers that utilize our efficient, cost-effective ecosystem. We intend for 2026 to be a year of investing for growth and launching new solutions to further penetrate the vast U.S. self-funded health insurance market. Our recently rolled out suite of more than 100 pre-configured, customized stop-loss plans as well as our new three-year rate stabilization program are poised to deliver meaningful revenue beginning in the second half of the year. We also are developing a data-driven offering that integrates physiological and claims data to generate actionable insights. By layering in new capabilities such as these onto our platform, we better serve our ecosystem partners and business employer end-clients, while creating new revenue streams and operating leverage for Health In Tech.”
Informational and educational content only. Not investment advice.